Trials / Completed
CompletedNCT01004653
A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines
An Open-Label Clinical Trial With Split-virion Influenza A/H1N1 Vaccines in Healthy Elders
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Sinovac Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
A single center, Open-Label phase IV clinical trial is to be conducted in healthy elders (equal to or more than 61 years to evaluate the immunogenicity and safety of Sinovac's 15μg H1N1 influenza A Vaccine (Split virion), Inactivated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | H1N1 influenza A Vaccine (Split virion), Inactivated | 100 elders were assigned to receive one dose of 15μg H1N1 influenza A Vaccine (Split virion), Inactivated |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2009-10-01
- Completion
- 2009-11-01
- First posted
- 2009-10-30
- Last updated
- 2013-03-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01004653. Inclusion in this directory is not an endorsement.